The surface activity and interaction with lipid monolayers and bilayers of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3phosphocholine (edelfosine) have been studied. Edelfosine is a surface-active soluble amphiphile, with critical micellar concentrations at 3.5 μM and 19 μM in water. When the air-water interface is occupied by a phospholipid, edelfosine becomes inserted in the phospholipid monolayer, increasing surface pressure. This increase is dose-dependent, and reaches a plateau at ca. 2 μM edelfosine bulk concentration. The ether lipid can become inserted in phospholipid monolayers with initial surface pressures of up to 33 mN/m, which ensures its capacity to become inserted into cell membranes. Upon interaction with phospholipid vesicles, edelfosine exhibits a weak detergent activity, causing release of vesicle contents to a low extent (b 5%), and a small proportion of lipid solubilization. The weak detergent properties of edelfosine can be related to its very low critical micellar concentrations. Its high affinity for lipid monolayers combined with low lytic properties support the use of edelfosine as a clinical drug. The surface-active properties of edelfosine are similar to those of other "single-chain" lipids, e.g. lysophosphatidylcholine, palmitoylcarnitine, or N-acetylsphingosine.
Introduction
The antitumour drug 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH 3 , edelfosine) represents the prototype of a group of synthetic antitumour ether lipids that show promising and selective antitumour activity and that, unlike most conventional chemotherapeutic drugs, do not target the DNA [1] [2] [3] . Edelfosine is accumulated in lipid rafts in tumour cells [4] [5] [6] , and induces apoptosis through a redistribution of lipid raft protein composition [4, [7] [8] [9] . However, little is known about the physical properties of edelfosine, and of its interaction with membrane lipids. Its structure, containing defined hydrophobic and hydrophilic moieties, suggests a potent surface activity, as found with structurally related biomolecules, e.g. lysopho-sphatidylcholine [10] , palmitoylcarnitine [11] , or N-acetylsphingosine [12] . All these molecules partition preferentially into the lipid bilayers in mixed aqueous dispersions of surfactant and phospholipid vesicles and some, e.g. N-acetylsphingosine, have a mild detergent activity, i.e. they are able to form phospholipidsurfactant mixed micelles [13] . Sánchez-Piñera et al. [14] described the effects of edelfosine on the polymorphic properties of dielaidoylphosphatidylethanolamine, demonstrating clear effects of the ether-lipid on the phospholipid phase behaviour. More recently, Torrecillas et al. [15] have described the effects of edelfosine and various analogues on the thermotropic phase transitions of phospholipids.
The present study is aimed at describing the surface-active properties of edelfosine in aqueous and bilayer environments. This ether lipid is found to interact with pure phosphatidylcholine monolayers and bilayers. Some of these properties may be relevant in the antitumour activity of edelfosine.
Materials and methods
Edelfosine was obtained from INKEYSA (Barcelona, Spain). 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was supplied by Avanti Polar Lipids (Alabaster, AL). Egg yolk phosphatidylcholine (ePC) was grade I from Lipid Products (South Nutfield, UK). 2-Anilinonaphthalene-6-sulphonic acid (ANS), lissamine™ rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (rhodamine DHPE), 8-aminonaphthalene-1,3,6-trisulfonic acid (disodium salt) (ANTS) and p-xylene-bis-pyridinium bromide (DPX) were from Molecular Probes, Inc. (Eugene, OR). Merocyanine 540 and Triton X-100 were provided by Sigma (St. Louis, MO). All assays were carried out in 10 mM HEPES, 150 mM NaCl, pH 7.4 buffer. All lipids were used without further purification. All other reagents were of analytical grade.
For liposome preparation, the proper amount of lipid was dissolved in chloroform:methanol (2:1, v/v) solution and the solvent evaporated exhaustively. Multilamellar vesicles (MLVs) were then prepared by hydrating the lipid film with buffer by vigorous vortexing. Large unilamellar vesicles (LUVs) were prepared by the extrusion method, passing the MLV suspension 10 times through polycarbonate filters 0.1 μm in pore diameter. Average size of the vesicles was ca. 0.1 μm as measured by quasi-elastic light scattering in a Malvern Zeta-Sizer 4 spectrometer. Final lipid concentration was measured in terms of lipid phosphorus.
Lipid monolayers and fluorescence measurements
Monomolecular layers at the interface were studied at 22°C using a μTrough-S equipment (Kibron, Helsinki, Finland) consisting on a small 2-cm rounded multi-well plate that allowed for 1 mm subphase measurements. Monolayers were formed by spreading a small amount of lipid (about 2 nmol) in chloroform:methanol (2:1, v/v) solution over assaying buffer. After allowing for solvent evaporation, edelfosine in buffer was added into the subphase through an adjusted hole. When formation of edelfosine monolayer was tested edelfosine was injected into the subphase without previous lipid spreading, following edelfosine transition to the interface in terms of changes in surface pressure. For fluorescence measurements, Rh-PE monolayers were formed at the interface at π = 20 mN/m and edelfosine was then injected into the subphase. After equilibration, aliquots were extracted from the subphase and assayed for rhodamine fluorescence by using an Aminco Bowman Series 2 luminescence spectrometer. The Rh-PE emission was followed at 590 nm (excitation wavelength at 530 nm) with a cut-off filter at 560 nm. Buffer was used as a zero for fluorescence signal.
CMC determination
Critical micellar concentration was measured at 22°C by mixing increasing concentrations of edelfosine in water (0 to 34 μM) with the hydrophobic dye Merocyanine 540 (final concentration 4 μM) [16] . Absorption spectra from the samples was then measured in an Uvikon 922 spectrophotometer and cmc was determined by an increase of about 25 nm in the absorption maximum wavelength (λ max ) of the dye upon merocyanine entrapping into edelfosine micelles. Alternatively, edelfosine was mixed with the fluorescent probe ANS (final concentration 2 μM) [16 bis], and ANS fluorescence emission was measured in a SLM-AMINCO 8100 spectrofluorometer (λ ex = 390 nm, λ em = 550 nm). In the ANS method the cmc is determined from an abrupt increase in fluorescence emission intensity.
Vesicle content efflux measurement
Large unilamellar vesicles were prepared in the presence of ANTS and DPX [17] . The lipid suspension was passed through a Sephadex G-25 column to discard non-encapsulated dye. Final lipid concentration was always 0.3 mM. Vesicle content efflux was measured at 22°C in an Aminco Bowman Series 2 luminescence spectrometer by following ANTS externalization after edelfosine addition. ANTS emission was recovered at 520 nm (excitation wavelength at 355 nm) with a cut-off filter at 450 nm. Initial vesicle suspension was used as the 0% fluorescence signal while 100% fluorescence was obtained after breakdown of the vesicles by addition of 1 mM Triton X-100.
Solubilization assays
Liposome suspensions were prepared in sucrose buffer (10 mM HEPES, 255 mM sucrose, pH 7.4) and diluted 10 times in assay buffer to diminish nonencapsulated sucrose concentration for a proper sedimentation. Sucrosecontaining vesicles were ultracentrifuged for 1 h at 100,000×g and 4°C, and the supernatant discarded. The pellet was resuspended in assay buffer and mixed with the same volumes of the appropriate edelfosine solutions in the same sucrose-free buffer. Final lipid vesicle concentration was always 1 mM. The mixtures were left to equilibrate for 1 h at 22°C, and solubilization was assayed from changes in turbidity. Turbidity was measured as absorbance at 500 nm (A 500 ) in an Uvikon 922 spectrophotometer. Turbidity values were normalized by setting 100% as the turbidity of the LUV suspension in the absence of edelfosine, while 0% turbidity corresponded to pure buffer [18] . After turbidity measurements, the solutions were again ultracentrifuged for 1 h at 125,000×g and 4°C, and vesicle solubilization followed in terms of lipid phosphorus in the supernatant.
Results
The surface-active properties of edelfosine were tested in a Langmuir balance. The ether lipid suspended in buffer was injected into the subphase, and the change in surface pressure (π) was recorded. Edelfosine caused a dose-dependent increase in surface pressure. Representative curves of π vs. time are shown in Fig. 1A . After a certain time, that decreased with increasing edelfosine concentrations, π remained constant. This constant value was operationally defined as an equilibrium value in this context. Equilibrium values of edelfosine-induced changes in surface pressure at the air-buffer interface are shown in Fig. 1B . These values increased with ether-lipid concentration up to ≈ 10 μM, and remained constant above that concentration. This represents probably the concentration at which edelfosine micelles start being formed, so that a regime of monomers-in-solution in equilibrium with monomers-at-theinterface is being replaced by a more complex equilibrium between monomers (interface), monomers (solution) and micelles (solution). In other words, the results in Fig. 1 show that edelfosine is a surface-active lipid with a critical micellar concentration (cmc) in the 5-10 μM range.
The cmc of edelfosine was studied in more detail using either the merocyanine 540 method of Kaschny and Goñi [16] or the ANS method [16 bis]. With merocyanine the cmc of surfactants is marked by an abrupt increase (of about 25 nm) in the absorption maximum wavelength (λ max ) corresponding to the merocyanine 540 monomer. The results in Fig. 2A indicate in fact two, rather than one, increases in λ max , corresponding probably to two different aggregation phenomena, i.e. formation of smaller and larger micelles. The observation of two cmcs for a given surfactant is unusual. This sort of behaviour was recently described by us for the short-chain ceramides [13] . The data in Fig. 2A indicated cmcs in buffer at 3.0 μM and 13 μM respectively. Cmc measurements performed with the ANS method provided very similar values (Fig. 2B) . The corresponding studies carried out in water gave values of 3.0 μM and 13 μM irrespective of the method used (data not shown).
The cmc observed at 3.0 μM by the merocyanine and ANS methods (Fig. 2) corresponds probably to the one detected at 5-10 μM with the Langmuir balance ( Fig. 1) . It is known that the so-called critical micelle concentration occurs in fact over a range of surfactant concentrations, and that the precise value obtained depends on the technique used, as well as on buffer, temperature, etc. [19] .
The insertion of edelfosine into phospholipid monolayers was tested using again the Langmuir balance, with preformed POPC monolayers at the air-buffer interface, and edelfosine injected into the subphase. POPC in excess water gave rise spontaneously to lipidic bilayers, thus it can be considered as a typical biomembrane phospholipid. Edelfosine insertion into a POPC monolayer at 20 mN/m increases lateral pressure in a dose-dependent form, as indicated in Fig. 3 . The π vs. edelfosine concentration curves reach a plateau at ca. 2-4 μM edelfosine. Again the behaviour of the ether lipid was very similar to the one observed for short-chain (N-acetyl) ceramide [13] . Edelfosine insertion-dependent increases in lateral pressure depend strongly on the initial π value. The plateau values of surface pressure increase (▵π) after edelfosine insertion are plotted as a function of initial π in Fig. 4 . The data can be fitted to a straight line, whose extrapolation to ▵π = 0 gives an idea of the maximum monolayer surface pressure that allows edelfosine insertion into monolayers. Edelfosine may become inserted into monolayers at initial π up to ≈ 32 mN/m. This is important because cell membranes are considered to support a lateral pressure π ≈ 30 mN/m [20] , albeit with large fluctuations around this average value. Thus the data in Fig. 4 indicate that edelfosine can insert easily into cell membranes, in agreement with its well-known effects at the cellular level.
The π vs. time curves in Fig. 3A show a maximum surface pressure that is achieved shortly after injection, then π values decrease slowly to their equilibrium values. This represents probably a fast partitioning of edelfosine into the monolayer, followed by a slow dispersion in the bulk water. The latter observation suggests in turn that edelfosine, above a given concentration, starts solubilizing the POPC monolayers, giving rise to POPC:edelfosine mixed micelles. This hypothesis was tested using a fluorescent phospholipid derivative, namely Rh-PE, whose behaviour in monolayers is very similar to that of POPC (data not shown). Rh-PE monolayers were formed at an initial π = 20 mN/m and edelfosine was injected into the subphase at bulk concentrations in the 0-50 μM concentration range. After allowing for equilibration, aliquots of the subphase were withdrawn and rhodamine fluorescence assayed. As shown in Fig. 5 , the ether lipid brought about the solubilization of Rh-PE. The presence of Rh-PE fluorescence in the aqueous phase can explain the decrease in surface pressure observed in Fig. 3A .
In view of the ability of edelfosine to solubilize phospholipids in monolayers, a number of experiments were performed next in which phospholipids were present in the form of bilayers. The capacity of edelfosine to break down the bilayer permeability barrier was tested using ePC large unilamellar vesicles in which ANTS/DPX had been entrapped. Edelfosine addition caused a dose-dependent, reproducible, though small release of vesicle aqueous contents (Fig. 6 ). Contents release was only detected above 18 μM edelfosine, i.e. above the second cmc as observed in Fig. 2 . Bilayer solubilization was assayed using two different methods, namely decrease in vesicle suspension turbidity and assay of lipid P in the supernatants after vesicle spin down. The turbidity method is commonly used because of its convenience, even if the results obtained are not quantitative [21] . The vesicles were incubated with the appropriate amounts of edelfosine and solubilization was observed as a decrease in vesicle suspension turbidity (Fig. 7A ). Again lipid bilayers are seen to be perturbed by the surfactant only at concentrations above the second cmc detected in Fig. 2 . Turbidity reaches a plateau when most of the bilayers remain non-solubilized. Higher edelfosine concentrations or higher incubation times failed to cause further decreases in turbidity. Vesicle solubilization was also assayed by centrifuging the surfactant-treated vesicles and assaying the fraction of lipid P remaining in the supernatant. The latter is assumed to be in the form of lipid-detergent mixed micelles. Vesicles loaded with concentrated sucrose were used in this experiment, in order to facilitate their sedimentation. The results in Fig. 7B show, in agreement with the turbidity data ( Fig. 7A ), that only a small fraction of the vesicles is solubilized. The capacity of edelfosine to bring about the bilayer-micelle transition is smaller than that of the short-chain ceramides [13] .
Discussion
The ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3phosphocholine, known as edelfosine, is an interesting anticancer drug because of its promising antitumour proapoptotic properties and its rather peculiar mechanism of action affecting the cell membrane [1, 3, 4] . In this study we have found that edelfosine is a surfactant molecule, that inserts readily into lipid monolayers and bilayers, and displays a low detergent activity.
Edelfosine should be considered as an amphiphile, because its molecule contains both lipophilic and hydrophilic moieties. In his classification of amphiphiles, Small [22] distinguished between non-swelling, swelling and soluble amphiphiles. According to the results in this paper, edelfosine should be classified as a "soluble amphiphile", mainly because it can be easily dispersed in water, up to at least 100 mM, giving rise to optically clear or slightly opalescent suspensions, and showing a discrete monomer-micelle transition. Other soluble amphiphiles include biomolecules such as the lysophospholipids, plateletactivating factor, or fatty acylcarnitines.
The soluble amphiphiles include also the commonly used detergents [23] . However, not all soluble amphiphiles have comparable detergent activities, i.e. not all of them are able to solubilize bilayers giving rise to lipid-detergent mixed micelles. Detergents used in membrane studies have cmc above 100 μM, and often above 1 mM [19, 24] . The cmc is, among other things, a measure of the affinity of the amphiphile molecules for each other, a higher affinity corresponding to a lower cmc. Apparently, very low cmcs suggest such a high affinity of the surfactant molecules for each other that their micelles can hardly accept a different amphiphile, i.e. the phospholipid, to generate mixed micelles, i.e. bilayer solubilization. The latter property is found in amphiphiles with a higher cmc. Lysophosphatidylcholines have cmcs in the 40-50 μM range, the corresponding value for palmitoylcarnitine is around 10 μM [25] , and, as shown in this paper, edelfosine has cmcs at ca. 3.5 μM and 19 μM. The latter three amphiphiles are very poor at solubilizing bilayers, as compared with, e.g. Triton X-100 (cmc ≈ 370 μM). It is interesting in this context that the mild detergent properties of edelfosine are only apparent above the highest of its two cmcs ( Figs. 6 and 7) . A low detergent activity of edelfosine has also been proposed by Torrecillas et al. [15] . The same authors have observed that edelfosine facilitates the lamellar-hexagonal transition of phosphatidylethanolamines. This would be in agreement with the expected molecular shape of a micelle-forming molecule, like edelfosine. It goes without saying that a high detergent potency would preclude the use of edelfosine as a clinical drug.
The results reported here showing the ready incorporation of edelfosine into membranes provide an explanation for the fact that this drug modifies plasma membrane lipid composition, resulting in selective association or/and displacement of crucial proteins with lipid raft scaffolds [4, 8, 9, 15] . The current findings on the weak detergent properties of edelfosine also give biophysical support to its specific and selective action on tumour cells [2] .
